What is William Blair’s Forecast for CNTX Q2 Earnings?
Context Therapeutics Inc. (NASDAQ:CNTX – Free Report) – Investment analysts at William Blair issued their Q2 2026 earnings estimates for Context Therapeutics in a report issued on Tuesday, April 29th. William Blair analyst M. Phipps forecasts that the company will post earnings of ($0.09) per share for the quarter. William Blair has a “Outperform” rating […]
